Sparta Systems Promotes William B. Gerraughty, Jr. to Chief Operating Officer
Sparta Systems, Inc., has promoted William B. Gerraughty, Jr., to the role of chief operating officer (COO). Gerraughty, who currently serves as chief financial officer (CFO), will assume the responsibility of overseeing the company’s day-to-day operations, provide strategic planning and resource allocation, and advise the CEO and management team on key planning issues and important business decisions. Gerraughty will continue to serve as CFO and manage the company’s legal and human resource departments.
Before Sparta Systems, Gerraughty served as CFO at two publicly traded companies, NMS Communications and Infinium Software. He also held a number of executive positions, including president, COO and CFO at Intellution, a software company serving the industrial automation markets. Gerraughty began his career at Coopers and Lybrand.
“William Gerraughty’s success in ensuring the financial health of Sparta Systems makes him a natural choice to oversee the company’s daily operation as we head into 2010,” said James E. McGowan, CEO, Sparta Systems. “I’m confident that with his unparalleled record of accomplishment and complete knowledge of the company’s inner workings, his promotion to COO will help position Sparta for continued growth in the coming year and beyond.”
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
